Investors who applied for the Hexagon Nutrition IPO may soon find out whether they have received shares.
The company’s public issue closed on June 9, 2026, after receiving an overwhelming response from investors.
According to exchange data, the IPO was subscribed 53.68 times overall, making it one of the closely watched SME offerings in recent days.
The basis of allotment is expected to be finalized on June 10, 2026.
Once the allotment process is completed, shares will be credited to successful applicants’ demat accounts, while refunds will be initiated for those who do not receive an allotment.
How to Check Hexagon Nutrition IPO Allotment Status
Investors can check their allotment status through the websites of NSE, BSE, or the issue registrar, KFin Technologies.
Check Allotment Status on NSE
Visit the NSE IPO allotment page.
Select “Equity and SME IPO Bid Details”.
Choose “HEXAGON” from the list.
Enter your PAN number and application number.
Click on Submit to view your allotment status.
Check Allotment Status on BSE
Open the BSE allotment status page.
Select “Equity” under Issue Type.
Choose Hexagon Nutrition Limited from the list.
Enter your PAN or application number.
Click Search to check your allotment status.
Check Allotment Status on KFin Technologies
Visit the KFin Technologies IPO status portal.
Select Hexagon Nutrition Limited from the dropdown menu.
Enter your PAN, application number, or demat account details.
Click Submit to view the result.
IPO Received Strong Investor Response
The Hexagon Nutrition IPO witnessed strong demand across all investor categories.
At the end of the bidding period, the issue received bids for 115.96 crore shares against the shares on offer, resulting in an overall subscription of 53.68 times.
Category-wise subscription figures were:
Qualified Institutional Buyers (QIBs): 19.77 times
Non-Institutional Investors (NIIs): 161.49 times
Retail Investors: 26.85 times
The exceptionally high interest from NIIs was one of the key highlights of the issue.
Hexagon Nutrition IPO: Key Details
The IPO was a book-built issue worth Rs 138.87 crore and consisted entirely of an Offer for Sale (OFS).
Since it was an OFS, the company itself will not receive any fresh funds from the issue.
Instead, the proceeds will go directly to the existing shareholders selling their stake.
The public issue opened on June 5 and closed on June 9, 2026.
Before the IPO opened, the company also raised Rs 41.66 crore from anchor investors.
Price Band and Minimum Investment
The IPO was offered at a price band of Rs 42 to Rs 45 per share.
Investors were required to bid for a minimum lot of 333 shares.
Based on the upper price band, the minimum investment for retail investors worked out to approximately Rs 14,985.
The share allocation was divided as follows:
50% reserved for Qualified Institutional Buyers (QIBs)
15% reserved for Non-Institutional Investors (NIIs)
35% reserved for Retail Investors
When Will Hexagon Nutrition Shares List?
Investors who receive allotment will not have to wait long for listing.
The shares of Hexagon Nutrition are expected to debut on both NSE and BSE on June 12, 2026.
Market participants will closely watch the listing performance, especially after the strong subscription numbers seen during the IPO.
About Hexagon Nutrition
Founded in 1993, Hexagon Nutrition is a nutrition-focused company engaged in manufacturing and marketing micronutrient premixes, clinical nutrition products, therapeutic formulations, and ready-to-use foods.
The company’s product portfolio includes well-known brands such as:
Pentasure
Obesigo
Pediagold
Nutrone
Hexagon Nutrition operates manufacturing facilities in Nasik, Chennai, and Thoothukudi, along with an overseas unit in Uzbekistan.
The company exports its products to more than 75 countries and sells through pharmacies, hospitals, e-commerce platforms, and online healthcare channels.
With dedicated research and development centers in Nasik and Chennai, the company continues to focus on nutrition innovation and expanding its global presence.
For investors, today’s allotment announcement will be the next major milestone before the stock’s expected market debut on June 12.
